Avestar Capital’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Avestar Capital's AZN Position: Q3 2026 in Review
Avestar Capital reduced its AstraZeneca (AZN) stake by 49% in Q3 2026, selling an estimated $558K and leaving 3,486 shares worth $566K. The position accounts for 0.04% of the portfolio, ranked #333.
Avestar Capital first reported a position in AZN in Q4 2017 and has held it in 25 quarters since. The position peaked at $1.29M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Avestar Capital held 3,486 shares of AstraZeneca worth $566K as of Q3 2026.
- Avestar Capital sold 3,350 AstraZeneca shares in Q3 2026, an estimated $558K.
- AstraZeneca made up 0.04% of Avestar Capital's portfolio in Q3 2026, its #333 holding.
- Avestar Capital first reported a position in AstraZeneca in Q4 2017 and has held it in 25 quarters since.
- Avestar Capital's AstraZeneca position peaked at $1.29M in Q4 2025.
- 1,333 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Avestar Capital's 13F filing for Q3 2026, filed 28 Oct 2026.